Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC
NCT ID: NCT04912882
Last Updated: 2021-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
1000 participants
OBSERVATIONAL
2021-06-15
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Detection of Circulating Tumor Cells (CTCs) in Patients With Colorectal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02450422
Treatment Response Prediction System of mCRC Patients Based on CTC
NCT04917276
A Cohort of Molecular Characteristics and Prognosis of Colorectal Cancer
NCT05086601
Diagnosis, Treatment, and Prevention of Colorectal Cancer Amid Abnormal Lipid Metabolism
NCT06886022
Circulating Tumor DNA Methylation Guided Postoperative Follow-up Strategy for Non-metastatic Colorectal Cancer
NCT05904665
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training Group
Training group including about 500 patients that be using to building the prognosis model
Circulating tumor cell
detecting circulating tumor cell pre- and post operatively
Validation Group
Validation group including about another 500 patients that be using to validating the prognosis model
Circulating tumor cell
detecting circulating tumor cell pre- and post operatively
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Circulating tumor cell
detecting circulating tumor cell pre- and post operatively
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Histologically proven colorectal carcinoma (TNM stage I-IV)
R0 resection is possible according to preoperative evaluation
Written informed consent for participation in the trial.
Exclusion Criteria
Receiving any preoperative treatment (Including chemotherapy, radiotherapy and target therapy)
Have other malignant tumors meanwhile
Other previous malignancy within 5 years
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZSCTC1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.